Bluejay diagnostics announces pricing of $3.5 million public offering

Acton, mass., dec. 28, 2023 (globe newswire) -- bluejay diagnostics, inc. (nasdaq: bjdx) (“bluejay” or the “company”), a medical technology company developing rapid diagnostics on its symphony platform to improve patient outcomes in critical care settings, today announced the pricing of a public offering of 2,692,308 shares of the company's common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 2,692,308 shares of common stock at a combined offering price of $1.30 per share (or pre-funded warrant in lieu thereof) and associated warrant. the warrants will have an exercise price of $1.30 per share and will be immediately exercisable upon issuance for a period of five years following the date of issuance. the closing of the offering is expected to occur on or about january 2, 2024, subject to the satisfaction of customary closing conditions.
BJDX Ratings Summary
BJDX Quant Ranking